ADVFN Logo

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for charts Register for streaming realtime charts, analysis tools, and prices.

SUMM Summit Therapeutics Plc

20.50
0.00 (0.00%)
Last Updated: 00:00:00
Delayed by 15 minutes
Share Name Share Symbol Market Type Share ISIN Share Description
Summit Therapeutics Plc LSE:SUMM London Ordinary Share GB00BN40HZ01 ORD 1P
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  0.00 0.00% 20.50 18.00 23.00 0.00 00:00:00
Industry Sector Turnover Profit EPS - Basic PE Ratio Market Cap
0 0 N/A 0

Summit Therapeutics plc Summit Therapeutics Plc : Holding(s) In Company

02/05/2018 3:30pm

UK Regulatory


 
TIDMSUMM 
 
 
   TR-1: Standard form for notification of major holdings 
 
 
 
 
NOTIFICATION OF MAJOR HOLDINGS (to be sent to the 
 relevant issuer and to the FCA in Microsoft Word format 
 if possible)(i) 
 
1a. Identity of the issuer or the underlying issuer 
 of existing shares to which voting rights are attached(ii)                                                                                          Summit Therapeutics PLC 
 :                                                                                                                                                         Sedol BN40HZ0 
1b. Please indicate if the issuer is a non-UK issuer 
 (please mark with an "X" if appropriate) 
Non-UK issuer 
2. Reason for the notification (please mark the appropriate 
 box or boxes with an "X") 
An acquisition or disposal of voting rights 
An acquisition or disposal of financial instruments 
An event changing the breakdown of voting rights                                                                                                                                                  X 
Other (please specify)(iii) : 
3. Details of person subject to the notification obligation(iv) 
                                                                                                         (1) Lansdowne Partners International Limited 
                                                                                                          (2) Lansdowne Partners Limited 
Name                                                                                                      (3) Lansdowne Partners (UK) LLP 
City and country of registered office (if applicable)                                                    London, United Kingdom 
4. Full name of shareholder(s) (if different from 
 3.)(v) 
 
                                                                                                           HSBC Client Holdings Nominee (UK) Ltd 
                                                                                                           HSBC Bank Plc Lansdowne Markets 
                                                                                                           Morgan Stanley Client Securities Nominees Limited 
Name                                                                                                       (Registered Shareholders) 
City and country of registered office (if applicable)                                                    N/A 
5. Date on which the threshold was crossed or reached(vi) 
 :                                                                                                       30/04/2018 
6. Date on which issuer notified (DD/MM/YYYY):                                                           02/05/2018 
7. Total positions of person(s) subject to the notification 
 obligation 
                                                     % of voting rights attached to shares (total of 8.  % of voting rights through financial instruments  Total of both in 
                                                                             A)                                      (total of 8.B 1 + 8.B 2)               % (8.A + 8.B)    Total number of voting rights of issuer(vii) 
Resulting situation on the date on which threshold 
 was crossed or reached                                                                          16.05%                                             9.74%            25.79%                                    81,989,004 
Position of previous notification (if 
 applicable)                                                                                     15.68%                                            11.30%            26.99% 
 
 
 
 
 
 
 8. Notified details of the resulting situation on 
 the date on which the threshold was crossed or reached(viii) 
A: Voting rights attached to shares 
Class/type of 
 shares 
 ISIN code (if possible)                                   Number of voting rights(ix)                                 % of voting rights 
                                              Direct                                      Indirect                                            Direct                                            Indirect 
                             (Art 9 of Directive 2004/109/EC) (DTR5.1)   (Art 10 of Directive 2004/109/EC) (DTR5.2.1)        (Art 9 of Directive 2004/109/EC) (DTR5.1)         (Art 10 of Directive 2004/109/EC) (DTR5.2.1) 
GB00BN40HZ01                                                                                               13,160,170                                                                                                16.05% 
 
 
SUBTOTAL 8. A                                                      13,160,170                                                                                         16.05% 
 
B 1: Financial Instruments according to Art. 13(1)(a) 
 of Directive 2004/109/EC (DTR5.3.1.1 (a)) 
                                                                                                                         Number of voting rights that may be acquired if the 
Type of financial                                           Expiration                                      Exercise/                                          instrument is 
instrument                                                     date(x)                          Conversion Period(xi)                                   exercised/converted.                             % of voting rights 
American Depositary Shares 
 (ADS)                                                             N/A                                            N/A                                              7,983,330                                          9.74% 
                                                                                                      SUBTOTAL 8. B 1                                              7,983,330                                          9.74% 
 
B 2: Financial Instruments with similar economic effect 
 according to Art. 13(1)(b) of Directive 2004/109/EC 
 (DTR5.3.1.1 (b)) 
Type of financial          Expiration                                   Exercise/ Conversion                           Physical or cash    Number of voting rights            % of voting rights 
 instrument                 date(x)                                     Period (xi)                                    settlement(xii) 
 
 
                                                                                                                       SUBTOTAL 8.B.2 
 
 
 
 
 
 
9. Information in relation to the person subject to 
 the notification obligation (please mark the 
 applicable box with an "X") 
Person subject to the notification obligation is not 
 controlled by any natural person or legal entity and 
 does not control any other undertaking(s) holding 
 directly or indirectly an interest in the (underlying) 
 issuer(xiii) 
Full chain of controlled undertakings through which 
 the voting rights and/or the 
 financial instruments are effectively held starting 
 with the ultimate controlling natural person or legal 
 entity(xiv) (please add additional rows as necessary)                                                                                                          X 
                         % of voting rights if it equals or is higher than   % of voting rights through financial instruments if   Total of both if it equals or is higher than the notifiable 
       Name(xv)                       the notifiable threshold               it equals or is higher than the notifiable threshold                           threshold 
Lansdowne Partners 
 International Limited                                              16.05%                                                  9.74%                            25.79% 
Lansdowne Partners 
 Limited 
Lansdowne Partners (UK) 
 LLP                                                                16.05%                                                  9.74%                            25.79% 
 
10. In case of proxy voting, please identify: 
Name of the proxy holder 
The number and % of voting rights held 
The date until which the voting rights will be held 
 
11. Additional information(xvi) 
 
 
 
 
 
Place of completion  London 
Date of completion   02 May 2018 
 
 
 
   This announcement is distributed by Nasdaq Corporate Solutions on behalf 
of Nasdaq Corporate Solutions clients. 
 
   The issuer of this announcement warrants that they are solely 
responsible for the content, accuracy and originality of the information 
contained therein. 
 
   Source: Summit Therapeutics plc via Globenewswire 
 
 
  http://www.summitplc.com/ 
 

(END) Dow Jones Newswires

May 02, 2018 10:30 ET (14:30 GMT)

Copyright (c) 2018 Dow Jones & Company, Inc.

1 Year Summit Therapeutics Chart

1 Year Summit Therapeutics Chart

1 Month Summit Therapeutics Chart

1 Month Summit Therapeutics Chart

Your Recent History

Delayed Upgrade Clock